- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2020 1

Journal Article 1

1 Results

Refine Results

All Collections

Refine Results:

All Collections

Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases

CITE Title : Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases Personal Author(s) : Lo, Michael K.;Albariño, César G.;Perry, Jason K.;Chang, Silvia;Tchesnokov, Egor P.;Guerrero, Lisa;Chakrabarti, Ayan;Shrivastava-Ranjan, Punya;Chatterjee, Payel;McMullan, Laura K.;Martin, Ross;Jordan, Robert;Götte, Matthias;Montgomery, Joel M.;Nichol, Stuart T.;Flint, Mike;Porter, Danielle;Spiropoulou, Christina F.; Published Date : October 07 2020 Source : Proc Natl Acad Sci U S A. 2020; 117(43):26946-26954 URL : https://stacks.cdc.gov/view/cdc/97659 Lo, Michael K. et al. (2020). Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases. 117(43). Lo, Michael K. et al. "Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases" 117, no. 43 (2020) Lo, Michael K. et al. "Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases" vol. 117, no. 43, 2020 Export RIS Citation Information.

:

Lo, Michael K. ;

Albariño, César G.

October 07 2020 | Proc Natl Acad Sci U S A. 2020; 117(43):26946-26954

:

Remdesivir is a broad-spectrum antiviral nucleotide prodrug that has been clinically evaluated in Ebola virus patients and recently received emergency...

To see more results, try removing search filters or changing the search terms